Simple urine test could predict cancer drug success
NCT ID NCT07406646
Summary
This study looked for early signs in blood and urine that could predict whether advanced kidney cancer treatments are working. Researchers followed 91 patients receiving immunotherapy or targeted drugs, collecting samples during the first 16 weeks of treatment. They compared tiny genetic markers in these samples with standard scan results to see if the markers could forecast treatment response sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.